|
|
Volumn 57, Issue 1, 2002, Pages 91-92
|
|
Bilogical evolution of renal osteodystrophy after decreasing dialysate calcium from 1.75 to 1.6 mmol/l [2]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
CALCIUM;
PARATHYROID HORMONE;
PHOSPHATE BINDING AGENT;
PHOSPHORUS;
VITAMIN D;
DIALYSIS FLUID;
ADULT;
AGED;
CLINICAL FEATURE;
CONTROLLED STUDY;
DIALYSATE;
DISEASE SEVERITY;
DOSE RESPONSE;
FOLLOW UP;
HEMODIALYSIS;
HUMAN;
HYPERCALCEMIA;
LETTER;
PRESCRIPTION;
PREVALENCE;
RENAL OSTEODYSTROPHY;
RISK ASSESSMENT;
SECONDARY HYPERPARATHYROIDISM;
STATISTICAL ANALYSIS;
BLOOD;
CHEMISTRY;
CHRONIC KIDNEY FAILURE;
HYPERPARATHYROIDISM;
MIDDLE AGED;
STANDARD;
ADULT;
AGED;
CALCIUM;
DIALYSIS SOLUTIONS;
HUMANS;
HYPERPARATHYROIDISM;
KIDNEY FAILURE, CHRONIC;
MIDDLE AGED;
PARATHYROID HORMONE;
RENAL OSTEODYSTROPHY;
|
|
EID: 0036007125
PISSN: 03010430
EISSN: None
Source Type: Journal
DOI: 10.5414/cnp57091 Document Type: Letter |
|
Times cited : (7)
|
|
References (2)
|
